HOME >> BIOLOGY >> NEWS
Pollen productionand allergiesmay rise significantly over next 50 years

Boston, MARising carbon dioxide levels associated with global warming could lead to an increase in the incidence of allergies to ragweed and other plants by mid-century, according to a report appearing in the March Annals of Allergy, Asthma, and Immunology by Harvard University researchers. The study found that ragweed grown in an atmosphere with double the current carbon dioxide levels produced 61 percent more pollen than normal. Such a doubling of atmospheric carbon dioxide is expected to occur between 2050 and 2100.

"The side effects of carbon dioxide, as well as its impact on heat budget and the water cycle, have to be taken very seriously," said Paul Epstein, MD, Harvard Medical School instructor in medicine and associate director of the Center for Health and the Global Environment at HMS. "I believe this study can help us understand the true costs of burning fossil fuels."

Ragweed, which flourishes along roadsides and in disturbed habitats throughout North America, produces one of the most common allergens. The researchers grew ragweed plants from seeds in two different enclosed environments. One was maintained at 350 parts carbon dioxide to a million parts air, which is roughly the current level. The other module was maintained at 700 parts carbon dioxide to a million parts air.

The indoor ragweed pollen results61 percent more in the second moduleecho the findings of a recent study conducted outdoors in North Carolina, said Epstein. In that study, excess carbon dioxide was pumped into a pine forest, tripling the number of pine cones and seeds. "It is a very important study because it shows how carbon dioxide affects different plant parts," he said. Taken together, the studies suggest that under carbon dioxide-enriched conditions, plants may boost production of their propagative elements to enhance their reproductive success.

In addition to producing more allergensand possibly more allergy suffererssuch a trend could alter compe
'"/>

Contact: John Lacey
public_affairs@hms.harvard.edu
617-432-0442
Harvard Medical School
20-Mar-2002


Page: 1 2

Related biology news :

1. Pollen record from Chilean lakes indicates global "togetherness" during last ice age
2. Allergy And Asthma-Exaceberating Mites, Molds And Pollens On The Rise Due To El Niño . . . La Niña
3. Rare mutations can significantly increase risk factor for heart disease
4. Cancer health risk significantly underestimated by EPAs ambient model estimates
5. Double mastectomies significantly lower risk of breast cancer in women who are genetically at risk
6. HAART therapy significantly prolongs survival in AIDS patients with central nervous system lymphoma
7. ENBREL rapidly, significantly improved back pain, mobility, function in ankylosing spondylitis
8. Once weekly ENBREL significantly reduced rheumatoid arthritis pain, inflammation & improved function
9. Cognitive abilities increase significantly with time in most prematurely born children
10. Combining key ingredients of vegetarian diet cuts cholesterol significantly, says study
11. Actonel significantly reduced moderate and severe vertebral fractures

Post Your Comments:
(Date:10/15/2014)... the 44th Rosenstiel Award for Distinguished Work in Biomedical ... the mechanisms of genomic instability and its implications for ... second alumnus to win the Rosenstiel Award; the first, ... Alt is the Charles A. Janeway Professor of Pediatrics ... an investigator at the Howard Hughes Medical Institute at ...
(Date:10/14/2014)... shows SIRT6—a protein known to inhibit the growth ... skin cancers by turning on an enzyme that increases ... Previously considered protective, SIRT6 is part of a family ... stability and prevent some of the genetic flaws associated ... lead to cancer. This study, in the journal,s October ...
(Date:10/14/2014)... of the planet,s leading questions is how to produce ... variable climate. The Food and Agriculture Organization of the ... over the next 40 years to feed a growing ... the necessary rise in food production. Plants—grains, cereals, ... supporting livestock. Current research must tap into our ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
(Date:10/22/2014)... YORK , Oct. 22, 2014 Nuvilex, ... Federation, approximately 400 million people worldwide are living with ... million people by 2030.  The global market for diabetes ... 2012 approximately 330,000 people worldwide died from pancreatic cancer.  ... death due to cancer in the United ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: